The concerns of October 10, 1857, sound remarkably familiar today.
Ophthalmology Times: September/October 2026
A solo surgeon explains how automation replaced his front desk, scheduling, and billing staff.
Sequencing IOL choice by eye can ease patient decision paralysis.
Concurrent exudative disease, early intervention, and a rare masquerader complicate the classic picture of geographic atrophy.
Epithelial basement membrane dystrophy can affect premium IOL outcomes.
A checklist could help keep patients with geographic atrophy on track.
Influence on effective lens position in cataract and lens-based surgery.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
AAO 2026: Optogenetic gene therapy heads to phase 2 trial in geographic atrophy
2
AAO 2026: BRUNELLO 1-year results for remigromig in DME
3
AAO 2026: DAYBREAK shows tarcocimab and tabirafusp-ted noninferior to aflibercept in wet AMD
4
Slowing Stargardt: What a 36% reduction in lesion growth could mean for adolescent patients
5